Publications by authors named "Matthew Menza"

Claim this Profile
T
Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.
Roseanne D Dobkin, Sarah L Mann, Michael A Gara, Alejandro Interian, Kailyn M Rodriguez, Matthew Menza

Neurology· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
Kevin J Black, Henry Nasrallah, Stuart Isaacson, Mark Stacy, Rajesh Pahwa, Matthew A Menza

CNS Spectr· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease.
Roseanne D Dobkin, Sarah L Mann, Alejandro Interian, Michael A Gara, Matthew Menza

Int J Geriatr Psychiatry· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
Kevin J Black, Henry Nasrallah, Stuart Isaacson, Mark Stacy, Rajesh Pahwa, Matthew A Menza

CNS Spectr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Telemedicine for Depression in Parkinson's Disease: A Pilot Trial.
Roseanne D Dobkin, Alejandro Interian, John Logan Durland, Michael A Gara, Matthew A Menza

J Geriatr Psychiatry Neurol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the Management of Parkinson's Disease: Focus on Psychosis.
Nicole J Brandt, Jack J Chen, Matthew Menza

Consult Pharm· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.
Roseanne D Dobkin, Alexander I Tröster, Jade Tiu Rubino, Lesley A Allen, Michael A Gara, Matthew Menza

J Neuropsychiatry Clin Neurosci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to mental health care utilization in Parkinson's disease.
Roseanne D Dobkin, Jade Tiu Rubino, Jill Friedman, Lesley A Allen, Michael A Gara, Matthew Menza

J Geriatr Psychiatry Neurol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease.
Roseanne D Dobkin, Jade Tiu Rubino, Lesley A Allen, Jill Friedman, Michael A Gara, Matthew Menza

J Consult Clin Psychol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telephone-based cognitive-behavioral therapy for depression in Parkinson disease.
Roseanne D Dobkin, Matthew Menza, Lesley A Allen, Jade Tiu, Jill Friedman

J Geriatr Psychiatry Neurol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.
Roseanne D Dobkin, Matthew Menza, Lesley A Allen, Michael A Gara, Margery H Mark

Am J Psychiatry· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.
Roseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, Michael Gara, Humberto Marin

Am J Geriatr Psychiatry· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.
Matthew Menza, Roseanne Defronzo Dobkin, Humberto Marin, Margery H Mark, Michael Gara

Psychosomatics· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.
Roseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, Michael Gara, Humberto Marin

J Neuropsychiatry Clin Neurosci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.
Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Michael Gara, Karina Bienfait

Mov Disord· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher serum caffeine in smokers with schizophrenia compared to smoking controls.
Kunal K Gandhi, Jill M Williams, Matthew Menza, Magdalena Galazyn, Neal L Benowitz

Drug Alcohol Depend· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbances in Parkinson's disease.
Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Karina Bienfait

Mov Disord· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
Karina L Bienfait, Matthew Menza, Margery H Mark, Roseanne D Dobkin

J Clin Neurosci· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study.
Roseanne Defronzo Dobkin, Matthew Menza, Lesley A Allen, Humberto Marin, Karina L Bienfait

Ann Clin Psychiatry· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.
Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Margery H Mark, Michael Gara

Mov Disord· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramelteon for the treatment of insomnia in menopausal women.
Roseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait, Lesley A Allen, Humberto Marin

Menopause Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach.
Roseanne DeFronzo Dobkin, Matthew Menza, Karina L Bienfait

Expert Rev Neurother· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trazodone and ejaculatory inhibition.
Kenneth R Kaufman, Humbarto Marin, Matthew Menza

J Sex Marital Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study.
Roseanne DeFronzo Dobkin, Lesley A Allen, Matthew Menza

Mov Disord· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Matthew A Menza, Roseanne D Dobkin, Humberto Marin

J Clin Psychopharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis